Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | MT-CO2 | P00403 | 4/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TEK | Q02763 | 1/20 | 0.32 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL895510 | 0.95 | CA1 (0.42) | CA1CA2CA4MT-CO2ALOX5 | |
| SCHEMBL22397285 | 0.95 | CA1 (0.42) | CA1CA2CA4MT-CO2ALOX5 | |
| SCHEMBL11955 | 0.95 | CA1 (0.42) | CA1CA2CA4MT-CO2ALOX5 | |
| SCHEMBL12333841 | 0.95 | CA1 (0.42) | CA1CA2CA4MT-CO2ALOX5 | |
| SCHEMBL120444 | 0.95 | CA1 (0.42) | CA1CA2CA4MT-CO2ALOX5 | |
| SCHEMBL9695672 | 0.92 | CA1 (0.46) | CA1CA2CA4MT-CO2ALOX5 | |
| SCHEMBL31276198 | 0.92 | KMT2A (0.44) | CA1CA2CA4MT-CO2ALOX5 | |
| SCHEMBL29107476 | 0.92 | CA1 (0.46) | CA1CA2CA4MT-CO2ALOX5 | |
| SCHEMBL8902053 | 0.92 | KMT2A (0.44) | CA1CA2CA4MT-CO2ALOX5 | |
| SCHEMBL3728524 | 0.92 | KMT2A (0.44) | CA1CA2CA4MT-CO2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12371642-B2 | Benefit agent containing delivery particle | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-29 | — | — | US | disclosed |
| US-20230313084-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2023-10-05 | — | — | US | disclosed |
| US-11713437-B2 | Benefit agent containing delivery particle slurries | THE PROCTER & GAMBLE COMPANY (US) | 2023-08-01 | — | — | US | disclosed |
| US-11708546-B2 | Benefit agent containing delivery particle | THE PROCTER & GAMBLE COMPANY (US) | 2023-07-25 | — | — | US | disclosed |
| US-11334695-B2 | Antiperspirant and deodorant compositions comprising malodor reduction compositions | THE PROCTER & GAMBLE COMPANY (US) | 2022-05-17 | — | — | US | disclosed |
| US-11334694-B2 | Personal care compositions comprising malodor reduction compositions | THE PROCTER & GAMBLE COMPANY (US) | 2022-05-17 | — | — | US | disclosed |
| WO-2021162115-A1 | LAMINATE, DISPLAY DEVICE, AND ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE | 富士フイルム株式会社 | 2021-08-19 | — | — | WO | disclosed |
| US-20210026199-A1 | COLORANT FILTER, BACKLIGHT UNIT, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2021-01-28 | — | — | US | disclosed |
| US-10806683-B2 | Encapsulated perfume compositions | GIVAUDAN SA (CH) | 2020-10-20 | — | — | US | disclosed |
| US-10792384-B2 | Rolled fibrous structures comprising encapsulated malodor reduction compositions | THE PROCTER & GAMBLE COMPANY (US) | 2020-10-06 | — | — | US | disclosed |
| WO-2012100423-A1 | ANALGESIC COMPOUNDS, METHODS, AND FORMULATIONS | ELI LILLY AND COMPANY (US) | 2012-08-02 | — | — | WO | disclosed |
| WO-2008089093-A2 | EFFICIENT PROCESSES FOR PREPARING STEROIDS AND VITAMIN D DERIVATIVES WITH THE UNNATURAL CONFIGURATION AT C20 (20 ALPHA-METHYL) FROM PREGNENOLONE | QUATRX PHARMACEUTICALS COMPANY (US) | 2008-07-24 | — | — | WO | disclosed |
| US-20080171728-A1 | Efficient Process for Preparing Steroids and Vitamin D Derivatives With the Unnatural Configuration at C20 (20 Alpha-Methyl) from Pregnenolone | QUATRX PHARMACEUTICALS CO. | 2008-07-17 | — | — | US | disclosed |
| US-20070135394-A1 | Process for the synthesis of vitamin d compounds and intermediates for the synthesis of the compounds | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-06-14 | — | — | US | disclosed |
| EP-1737468-A2 | TREATMENT OF INTERSTITIAL CYSTITIS WITH VITAMIN D COMPOUNDS | Bioxell S.p.a. (IT) | 2007-01-03 | — | — | EP | disclosed |
| CN-1798721-A | Cyclohexyl derivatives as selective estrogen receptor modulators | JANSSEN PHARMACEUTICA NV (BE) | 2006-07-05 | — | — | CN | disclosed |
| WO-2005082375-A2 | TREATMENT OF INTERSTITIAL CYSTITIS WITH VITAMIN D COMPOUNDS | BIOXELL SPA (IT) | 2005-09-09 | — | — | WO | disclosed |
| US-5641784-A | ADENOSINE ANTAGONISTS; TREATMENT OF NERVOUS SYSTEM DISORDERS, ALZHEIMER'S DISEASE | BOEHRINGER INGELHEIM KG (DE) | 1997-06-24 | — | — | US | disclosed |
| EP-0349204-A2 | Use and regeneration of reagents using coupled reactions and permselective barriers | BEND RESEARCH, INC. (US) | 1990-01-03 | — | — | EP | disclosed |
| US-4510321-A | Autoxidative cleavage of ketones in the presence of pulverized alkali metal hydroxide | ALLIED CORPORATION (US) | 1985-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171728-A1 | Efficient Process for Preparing Steroids and Vitamin D Derivatives With the Unnatural Configuration at C20 (20 Alpha-Methyl) from Pregnenolone | CYP2R1, CYP24A1, VDR | CA1 4295/4885CA2 4407/4885CA4 3748/4885 |
| US-20070135394-A1 | Process for the synthesis of vitamin d compounds and intermediates for the synthesis of the compounds | CYP24A1, CYP2R1, VDR | CA1 751/4885CA2 933/4885CA4 188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.